Key Statistics
Market Cap
$865.35M
P/E Ratio
-5.74
Dividend Yield
0.00%
Volume
78,359,344
Avg Volume
2,195,303
52-Week High
N/A
52-Week Low
N/A
About Day One Biopharmaceuticals, Inc.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.
Analyst Ratings
View All →
Avg Price Target
$26.00
(+22.6% upside)
